Clinical ink Selected for Global Late Phase Parkinson’s Disease Programs
December 14, 2022 10:47 ET
|
Clinical Ink
Horsham, PA, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Horsham, Pa.; December 14, 2022 — Clinical ink, a global life science technology company, has partnered with a leading biopharmaceutical organization...
Clinical ink Again Ranked Among Fastest-Growing Companies in North America on the 2022 Deloitte Technology Fast 500™
November 16, 2022 08:42 ET
|
Clinical Ink
Horsham, Pennsylvania, USA, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Horsham, Pennsylvania; November 16, 2022 — Clinical ink, a global life science technology company, today announced its second...
US Military Health System Research Study Deploys Clinical ink's Self-Testing Mobile Platform to Understand Long COVID
November 01, 2022 12:28 ET
|
Clinical Ink
Horsham, Pennsylvania, USA, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, has developed a self-testing app to measure cognitive impairment in patients...
Clinical ink Relaunches Industry-Leading Partner Program
September 19, 2022 10:45 ET
|
Clinical Ink
Horsham, Pennsylvania, USA, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Today Clinical ink, a global life science company, announces the relaunch and expansion of a unique contract research organization...
Clinical ink Debuts the Industry's Smartest eCOA Technology
September 14, 2022 11:02 ET
|
Clinical Ink
Horsham, Pennsylvania, USA, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Today Clinical ink, a global life science company, announces the launch of its new, configurable electronic clinical outcomes...
Oxford Team Adopts Clinical ink's Remote Monitoring Technology for Leading-Edge Parkinson's Study
August 11, 2022 12:16 ET
|
Clinical Ink
Horsham, Pennsylvania, USA, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, has partnered with the research team at the NeuroMetrology Lab, part of the...
Cutting-Edge Research Reveals Greater Insights into Parkinson’s Disease Progression
April 11, 2022 13:41 ET
|
Clinical Ink
Horsham, PA, April 11, 2022 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, today—World Parkinson’s Day—announces research that strengthens its standing as a critical...
Clinical Ink’s Technology Deployed for Groundbreaking Cannabis Research
February 17, 2022 07:00 ET
|
Clinical Ink
Horsham, PA, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Clinical Ink’s Technology Deployed for Groundbreaking Cannabis Research JAMA publication demonstrates assessment validity, points to future...
CLINICAL INK TO ACCELERATE INNOVATION AND GROWTH WITH MAJOR INVESTMENT BY NOVAQUEST PRIVATE EQUITY
May 14, 2018 07:00 ET
|
Clinical Ink
PHILADELPHIA, PA; RALEIGH, NC; and WINSTON-SALEM, NC, May 14, 2018 (GLOBE NEWSWIRE) -- Clinical Ink, the pioneering provider of eSource and next-generation ePRO/eCOA solutions for clinical...
Clinical Ink Extends eCOA and Risk-Based Monitoring Capabilities
April 21, 2017 12:00 ET
|
Clinical Ink
PHILADELPHIA, PA--(Marketwired - April 21, 2017) - Clinical Ink, the pioneering provider of eSource and patient engagement technologies for clinical trials, introduces the latest in a series of...